このパッケージに含まれるもの
医療処置
- 腫瘍専門医の診察
- 栄養士による1日3食
- 24時間看護サービス
- 心電図(ECG)
- 血液検査
- 胸部X線
- HIV抗体検査
- B型肝炎コア抗体検査
- 抗HCV抗体検査
- 心エコー図検査
- 全血球計算(CBC)
- 生化学血液検査
- PET/CT
- 腫瘍専門医との診察
- 血液専門医へのコンサルテーション
- 免疫専門医への相談
- 循環器科医への相談
- 小児血液専門医との相談
- 小児科医との相談
- 腫瘍血液専門医との診察
- 頭部MRI
- 生検
- 骨塩定量検査(CBM)
- 腫瘍マーカーおよび蛋白分画を含む全血球算定
期間
- 30 日 病院で
宿泊
入院
交通
空港-クリニック-空港間の送迎
追加情報
Bone Marrow Transplant for Pediatric Medulloblastoma
Sheba Medical Center – Advanced, Personalized Transplant Care for Children
At Sheba Medical Center, we understand how difficult it is for families to face a diagnosis of medulloblastoma. As the most common malignant brain tumor in children, it requires highly specialized and carefully coordinated care.
Today, one of the most important advances in treating medulloblastoma, especially in very young children, is the use of high-dose chemotherapy with stem cell support, also known as bone marrow transplantation (BMT).
At Sheba, this approach is a key part of modern treatment strategies designed not only to fight the tumor effectively, but also to protect the developing brain and support long-term quality of life.
The Role of Bone Marrow Transplant in Medulloblastoma
In pediatric medulloblastoma, BMT - more precisely called High-Dose Chemotherapy with Autologous Stem Cell Rescue (HDC-ASCR) - is a well-established and widely used treatment approach.
It plays a central role in:
Protecting the Developing Brain
In infants and very young children, this approach allows doctors to delay or avoid radiation therapy, helping preserve brain development and cognitive function while still delivering effective treatment.
Treating High-Risk Disease
In older children with higher-risk or more advanced disease, BMT is used as a consolidation phase following surgery and initial chemotherapy helping eliminate remaining cancer cells and strengthen treatment outcomes.
How the Treatment Works
Autologous Transplant (Child’s Own Cells)
This is the standard and most commonly used approach in medulloblastoma.
Stem cells are collected from the child in advance
High-dose chemotherapy is administered
The child’s own stem cells are reinfused to restore bone marrow and support recovery
Tandem (Multiple) Transplants
Many advanced protocols include two or more sequential transplant cycles.
This approach:
Increases treatment intensity in a controlled way
Enhances the ability to target remaining cancer cells
Is tailored individually to each child
Donor Options - Always a Solution Available
While most children with medulloblastoma are treated using their own stem cells, Sheba Medical Center also offers allogeneic (donor) transplantation when clinically appropriate.
If a donor-based approach is needed, our team ensures that every child has access to a suitable donor:
Matched sibling donors, when available
Matched unrelated donors through international registries
Haploidentical (half-matched) family donors, often a parent
With advanced matching technologies and global donor access, a suitable option can be identified even when a family match is not available.
Advanced Treatment Protocols
At Sheba Medical Center, treatment follows the most advanced international standards in pediatric neuro-oncology.
High-dose chemotherapy regimens may include:
Thiotepa – effective in reaching the brain
Carboplatin
Etoposide
Each treatment plan is carefully tailored to maximize effectiveness while supporting safety and recovery.
Precision, Safety, and Support
Children undergoing transplantation are treated in dedicated pediatric transplant units designed for both safety and comfort:
Child-friendly, highly protected environments
Advanced infection prevention systems
Continuous care by experienced pediatric specialists
Integrated Pediatric Neuro-Oncology Care
Care at Sheba is highly coordinated and personalized:
Integration of neurosurgery, chemotherapy, and transplant strategies
Access to advanced and targeted therapies
Close collaboration between neuro-oncologists, neurosurgeons, and transplant teams
Comprehensive supportive care throughout treatment
Clinical Expertise
Sheba Medical Center is a leading center for pediatric oncology and transplantation, offering:
Extensive experience in medulloblastoma and complex brain tumors
Expertise in HDC-ASCR and tandem transplant protocols
Outcomes aligned with leading international centers
Long-term follow-up focused on development and quality of life
Care That Supports the Whole Family
We understand that this journey affects the entire family.
At Sheba, families are supported by a multidisciplinary team including physicians, nurses, psychologists, and care coordinators ensuring guidance, reassurance, and continuous support at every stage.
Why Families Choose Sheba for Pediatric BMT
Leading pediatric transplant and neuro-oncology center
Expertise in advanced medulloblastoma treatment
Experience with radiation-sparing protocols
Ability to secure optimal donors when needed
Personalized, child-centered care
Dedicated international patient services
A Message of Hope
At Sheba Medical Center, we combine advanced science with compassionate pediatric care. Through innovative approaches like high-dose chemotherapy with stem cell support, we aim not only to treat medulloblastoma effectively, but also to protect each child’s future supporting families with confidence, care, and hope every step of the way.
24時間年中無休Bookimedサポート
- 専任医療コーディネーター
- 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
- 医療旅行中の患者擁護
プログラム料金
このパッケージに含まれないもの
医師
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
調子はいかがですか?
クリニックについて
シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。